LON:POLX Polarean Imaging (POLX) Share Price, News & Analysis GBX 1.38 -0.02 (-1.64%) As of 07/3/2025 06:15 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesBuy This Stock About Polarean Imaging Stock (LON:POLX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Polarean Imaging alerts:Sign Up Key Stats Today's Range 1.30▼ 1.5050-Day Range 0.91▼ 1.4552-Week Range 0.85▼ 2Volume251,088 shsAverage Volume2.59 million shsMarket Capitalization£20.21 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Polarean is a revenue-generating medical imaging technology company revolutionizing pulmonary medicine through direct visualization of lung function by introducing the power and safety of MRI to the respiratory healthcare community. This community is in desperate need of modern solutions to accurately assess lung function. The Company strives to optimize lung health and prevent avoidable loss by illuminating hidden disease, addressing the global unmet medical needs of more than 500 million patients worldwide suffering from chronic respiratory disease. Polarean is a leader in the field of hyperpolarization science and has successfully developed the first and only hyperpolarized Xenon MRI inhaled contrast agent, XENOVIEW™, which is now FDA-approved in the United States. Polarean is dedicated to researching, developing, and commercialising innovative imaging solutions with its non-invasive and radiation-free pulmonary functional MRI platform. This comprehensive drug-device platform encompasses the proprietary Xenon gas blend, gas hyperpolarization system, as well as software and accessories, facilitating fully integrated modern respiratory imaging operations. Founded in 2012, with offices in Durham, NC, and London, United Kingdom, Polarean is committed to increasing global awareness of and broad access to its XENOVIEW MRI technology platform. For the latest news and information about Polarean, please visit www.polarean.com Read More Receive POLX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Polarean Imaging and its competitors with MarketBeat's FREE daily newsletter. Email Address POLX Stock News HeadlinesFDA expands XENOVIEW® indication to include children from six years of ageJune 2, 2025 | finance.yahoo.comPolarean Imaging’s Xenon MRI gains traction in pulmonary medicineMay 17, 2025 | uk.investing.comWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington. | Altimetry (Ad)Polarean Imaging Full Year 2024 Earnings: Revenues Beat ExpectationsMay 10, 2025 | finance.yahoo.comPolarean Imaging, SimonMed collaborate to advance lung imagingJanuary 28, 2025 | markets.businessinsider.comPolarean and SimonMed Announce Collaboration to Advance Lung Imaging InnovationJanuary 28, 2025 | finance.yahoo.comAmati Global Investors Reduces Stake in Polarean ImagingDecember 12, 2024 | markets.businessinsider.compolarean Share Chat (POLX)October 19, 2024 | lse.co.ukSee More Headlines POLX Stock Analysis - Frequently Asked Questions How have POLX shares performed this year? Polarean Imaging's stock was trading at GBX 1.33 at the start of the year. Since then, POLX shares have increased by 3.9% and is now trading at GBX 1.38. How do I buy shares of Polarean Imaging? Shares of POLX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Polarean Imaging own? Based on aggregate information from My MarketBeat watchlists, some other companies that Polarean Imaging investors own include SSP Group (SSPG), Intel (INTC), Allena Pharmaceuticals (ALNA), ASOS (ASC), B&M European Value Retail (BME), BP (BP) and Coats Group (COA). Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolLON:POLX CIKN/A Webwww.polarean.com Phone919 206 7900FaxN/AEmployees28Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (3.89) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£69.44 million Net Margins-1,333.97% Pretax MarginN/A Return on Equity-86.11% Return on Assets-32.28% Debt Debt-to-Equity Ratio2.61 Current Ratio4.12 Quick Ratio9.80 Sales & Book Value Annual Sales£5.21 million Price / Sales3.88 Cash FlowGBX 0.28 per share Price / Cash Flow4.93 Book ValueGBX 3.30 per share Price / Book0.42Miscellaneous Outstanding Shares1,467,682,223Free FloatN/AMarket Cap£20.21 million OptionableNot Optionable Beta0.38 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report This page (LON:POLX) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Polarean Imaging plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Polarean Imaging With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.